US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 10.530
  • 0.0000.00%
Close Jul 24 16:00 ET
  • 10.530
  • 0.0000.00%
Post 16:30 ET
184.89MMarket Cap-9572P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
13.29%29.53M
-2.79%116.88M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
-19.43%120.24M
151.25%51.28M
4.02%22.41M
13.53%29.82M
Operating revenue
18.11%41.96M
5.00%159.65M
-21.19%48.07M
31.10%39.59M
-9.84%26.89M
112.27%35.52M
-9.18%152.05M
58.08%61M
40.18%30.2M
13.53%29.82M
Cost of revenue
107.27%2.03M
306.52%7.11M
1,008.19%3.79M
407.20%1.27M
3.76%1.08M
707.44%977K
61.50%1.75M
-29.77%342K
65.56%250K
703.10%1.04M
Gross profit
9.63%27.51M
-7.36%109.77M
-37.17%32M
21.24%26.87M
-10.33%25.81M
51.04%25.09M
-20.02%118.49M
155.68%50.94M
3.59%22.16M
10.12%28.78M
Operating expense
-8.84%34.48M
-24.58%130.26M
-36.82%30.04M
-22.76%31.33M
-25.56%31.08M
-11.79%37.82M
9.93%172.72M
25.70%47.54M
-1.49%40.56M
6.54%41.75M
Selling and administrative expenses
2.60%28.45M
-5.97%105.74M
-16.54%26.85M
-4.02%24.86M
-2.50%26.31M
1.20%27.73M
22.37%112.45M
31.23%32.17M
13.20%25.9M
20.57%26.98M
Research and development costs
-40.27%6.03M
-59.31%24.52M
-79.26%3.19M
-55.85%6.48M
-67.68%4.77M
-34.80%10.09M
-7.61%60.27M
15.49%15.37M
-19.86%14.67M
-12.14%14.77M
Operating profit
45.26%-6.97M
62.21%-20.49M
-42.16%1.97M
75.74%-4.47M
59.38%-5.27M
51.54%-12.73M
-504.23%-54.23M
118.99%3.4M
6.99%-18.4M
0.64%-12.97M
Net non-operating interest income expense
-57.95%-1.28M
-52.17%-4.6M
-81.27%-1.23M
-93.53%-1.23M
-152.94%-1.33M
31.50%-811K
37.19%-3.02M
47.16%-678K
51.34%-634K
69.76%-527K
Non-operating interest income
50.89%593K
232.16%2.27M
58.04%678K
250.00%672K
1,159.52%529K
1,771.43%393K
1,355.32%684K
2,581.25%429K
1,271.43%192K
162.50%42K
Non-operating interest expense
55.65%1.87M
85.38%6.87M
72.27%1.91M
129.90%1.9M
227.24%1.86M
-0.08%1.2M
-23.72%3.71M
-14.78%1.11M
-37.28%826K
-67.65%569K
Other net income (expense)
62.51%-1.32M
Special income (charges)
----
--0
----
----
----
----
62.51%-1.32M
----
----
----
-Less：Restructuring and merger&acquisition
----
--0
----
----
----
----
-62.51%1.32M
----
----
----
Income before tax
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-238.40%-58.57M
106.17%1.4M
9.73%-19.04M
8.78%-13.49M
Income tax
0
0
Net income
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
Net income continuous Operations
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
Minority interest income
Net income attributable to the parent company
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
Basic earnings per share
37.50%-0.5
58.82%-1.4
0.00%0.1
72.73%-0.3
50.00%-0.4
50.00%-0.8
-209.09%-3.4
107.69%0.1
8.33%-1.1
0.00%-0.8
Diluted earnings per share
37.50%-0.5
58.82%-1.4
0.00%0.1
72.73%-0.3
50.00%-0.4
50.00%-0.8
-209.09%-3.4
107.69%0.1
8.33%-1.1
0.00%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 13.29%29.53M-2.79%116.88M-30.20%35.79M25.54%28.13M-9.84%26.89M55.78%26.07M-19.43%120.24M151.25%51.28M4.02%22.41M13.53%29.82M
Operating revenue 18.11%41.96M5.00%159.65M-21.19%48.07M31.10%39.59M-9.84%26.89M112.27%35.52M-9.18%152.05M58.08%61M40.18%30.2M13.53%29.82M
Cost of revenue 107.27%2.03M306.52%7.11M1,008.19%3.79M407.20%1.27M3.76%1.08M707.44%977K61.50%1.75M-29.77%342K65.56%250K703.10%1.04M
Gross profit 9.63%27.51M-7.36%109.77M-37.17%32M21.24%26.87M-10.33%25.81M51.04%25.09M-20.02%118.49M155.68%50.94M3.59%22.16M10.12%28.78M
Operating expense -8.84%34.48M-24.58%130.26M-36.82%30.04M-22.76%31.33M-25.56%31.08M-11.79%37.82M9.93%172.72M25.70%47.54M-1.49%40.56M6.54%41.75M
Selling and administrative expenses 2.60%28.45M-5.97%105.74M-16.54%26.85M-4.02%24.86M-2.50%26.31M1.20%27.73M22.37%112.45M31.23%32.17M13.20%25.9M20.57%26.98M
Research and development costs -40.27%6.03M-59.31%24.52M-79.26%3.19M-55.85%6.48M-67.68%4.77M-34.80%10.09M-7.61%60.27M15.49%15.37M-19.86%14.67M-12.14%14.77M
Operating profit 45.26%-6.97M62.21%-20.49M-42.16%1.97M75.74%-4.47M59.38%-5.27M51.54%-12.73M-504.23%-54.23M118.99%3.4M6.99%-18.4M0.64%-12.97M
Net non-operating interest income expense -57.95%-1.28M-52.17%-4.6M-81.27%-1.23M-93.53%-1.23M-152.94%-1.33M31.50%-811K37.19%-3.02M47.16%-678K51.34%-634K69.76%-527K
Non-operating interest income 50.89%593K232.16%2.27M58.04%678K250.00%672K1,159.52%529K1,771.43%393K1,355.32%684K2,581.25%429K1,271.43%192K162.50%42K
Non-operating interest expense 55.65%1.87M85.38%6.87M72.27%1.91M129.90%1.9M227.24%1.86M-0.08%1.2M-23.72%3.71M-14.78%1.11M-37.28%826K-67.65%569K
Other net income (expense) 62.51%-1.32M
Special income (charges) ------0----------------62.51%-1.32M------------
-Less：Restructuring and merger&acquisition ------0-----------------62.51%1.32M------------
Income before tax 39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-238.40%-58.57M106.17%1.4M9.73%-19.04M8.78%-13.49M
Income tax 00
Net income 39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M
Net income continuous Operations 39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M
Minority interest income
Net income attributable to the parent company 39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M
Basic earnings per share 37.50%-0.558.82%-1.40.00%0.172.73%-0.350.00%-0.450.00%-0.8-209.09%-3.4107.69%0.18.33%-1.10.00%-0.8
Diluted earnings per share 37.50%-0.558.82%-1.40.00%0.172.73%-0.350.00%-0.450.00%-0.8-209.09%-3.4107.69%0.18.33%-1.10.00%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg